Bravigo Special Precautions

Patients must be advised to talk to the doctor or pharmacist before taking Bravigo: If the patient suffers from heart rhythm disorders (such as irregular heartbeat, palpitation, increase in chest pain) or sustained atrial fibrillation (a type of irregular heartbeat), or an abnormality of electrocardiogram (ECG) called 'long QT syndrome'. The risk of developing atrial fibrillation is increased in patients treated with ivabradine. It is recommended to regularly clinically monitor ivabradine treated patients for the occurrence of atrial fibrillation (sustained or paroxysmal), which should also include ECG monitoring if clinically indicated (e.g. in case of exacerbated angina, palpitations, irregular pulse). Patients should be informed of signs and symptoms of atrial fibrillation and be advised to contact their physician if these occur. If atrial fibrillation develops during treatment, the balance of benefits and risks of continued ivabradine treatment should be carefully reconsidered.
If the patient has symptoms such as tiredness, dizziness or shortness of breath (this could mean that the heart is slowing down too much).
If the patient suffers from symptoms of atrial fibrillation (pulse rate at rest unusually high (over 110 beats per minute) or irregular, without any apparent reason, making it difficult to measure).
If the patient has had a recent stroke (cerebral attack).
If the patient suffers from mild to moderate low blood pressure.
If the patient suffers from uncontrolled blood pressure, especially after a change in the antihypertensive treatment.
If the patient suffers from severe heart failure or heart failure with abnormality of ECG called 'bundle branch block'.
If the patient suffers from chronic eye retinal disease.
If the patient suffers from moderate liver problems.
If the patient suffers from severe renal problems.
If any of the previously mentioned apply to the patient, the patient must be advised to talk straight away to the doctor before or while taking Bravigo.
Bravigo contains lactose: If the patient has been told by the doctor that they have an intolerance to some sugars, they must be advised to contact the doctor before taking this medicine.
Driving and using machines: Bravigo may cause temporary luminous visual phenomena (a temporary brightness in the field of vision, see Side Effects). If this happens to the patient, the patient must be advised to be careful when driving or using machines at times when there could be sudden changes in light intensity, especially when driving at night.
Use in Children: Do not give this medicine to children and adolescents younger than 18 years. Available data are insufficient in this age group.